Pharma & Biotech
Acasti Pharma edging closer to commercializing CaPre as it eyes topline clinical data for Christmas
THC Global Group moves to product validation ahead of medicinal cannabis supply
Callitas Health capitalizes on CannaStrips, OTC goods while swinging for the fence with blockbuster drugs
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.